All Activity

Searching for Escorts in Connaught Place Hotel New Delhi gave me access to well-organized listings. The profiles were detailed, and communication was quick and clear. It helped in making decisions easily without second thoughts. Services in this location seem to focus on user satisfaction, offering a balanced mix of convenience and proper coordination.

I’m going to read this. I’ll be sure to come back. thanks for sharing. and also This article gives the light in which we can observe the reality. this is very nice one and gives indepth information. thanks for this nice article... situs toto

Awesome article, it was exceptionally helpful! I simply began in this and I'm becoming more acquainted with it better! Cheers, keep doing awesome! akongcuan

I am impressed. I don't think Ive met anyone who knows as much about this subject as you do. You are truly well informed and very intelligent. You wrote something that people could understand and made the subject intriguing for everyone. Really, great blog you have got here. สมัครสมาชิก ufabet

Very efficiently written information. It will be beneficial to anybody who utilizes it, including me. Keep up the good work. For sure i will check out more posts. This site seems to get a good amount of visitors. เข้าสู่ระบบ สมัครUFABET

On our website, you will discover the profiles of all Akshardham Escorts, complete with their descriptions and distinctive features. Our escorts will assist you in alleviating stress and satisfying your desires for adventurous intimacy or alluring foreplay. Book highly-rated escorts in Akshardham through us and experience a range of services.

“The issue isn’t whether the funds should be used, it’s how they’re used and whether we’re doing it in a responsible, sustainable way.” By Henry Culvyhouse, Mountain State Spotlight This story was originally published by Mountain State Spotlight. Get stories like this delivered to your email inbox once a week; sign up for the free newsletter at https://mountainstatespotlight.org/newsletter. In spite of a veto that could have further delayed the spending of $38 million in medical marijuana money collected over the last four years, state Treasurer Larry Pack (R) now says he will release the funds under the original mandate. Last week, Gov. Patrick Morrisey (R) vetoed a bill that would’ve required the release of medical marijuana funds to help the homeless and expedite child abuse and neglect cases in the court system. He said the bill tied up monies for future spending. In his veto letter, Morrisey wrote, “West Virginia must do better to plan for the future, and it can’t totally pre-commit future revenue streams like this if it’s going to have reserves to invest more in roads, water, sewer, site selection, rail, and future tax cuts.” Morrisey said he was willing to negotiate with the Legislature on how to spend the money. “The issue isn’t whether the funds should be used, it’s how they’re used and whether we’re doing it in a responsible, sustainable way,” governor’s office spokesman Lars Dalseide wrote in an email. But the money was already pre-committed in state code. Pack’s office said 100 percent of that money will now go to various offices and programs prescribed by the original law—more than half to the Office of Medical Cannabis and the remainder of the funds split between a grant program for substance abuse treatment and grants for law enforcement. The move ignores the governor’s wishes for future reserves to tackle infrastructure and tax cuts. In October, a Mountain State Spotlight investigation revealed $34 million had accumulated in an account held by the Treasurer’s Office from the state’s medical marijuana program. Pack’s office said the money hadn’t been spent because of legal concerns surrounding the drug. Currently, marijuana is listed as a Schedule I narcotic under federal law, meaning it has no medical use and is illegal. Pack isn’t the first state treasurer to express concern. State Treasurer John Perdue (D) said his office wouldn’t hold the money in 2018, following passage of the Medical Cannabis Act. Riley Moore (R), who beat Perdue in the 2020 race, never released the money, either. Going into the 2026 Legislative Session, Del. Evan Worrell, R-Cabell, said he read a report about the amassed funds and wanted to change it. He successfully ran a bill that would force the state to spend the money on a commission to to help thousands of child abuse and neglect court cases, and homelessness services. Had the governor not vetoed the bill, the money would have been designated to those things for one year. Money for substance abuse research, treatment and the abuse and neglect commission would continue in the following years. The Treasurer’s Office spokeswoman Carrie Smith said due to the complexity of state and federal laws, the office had been working to release the money for months. She said the money has now been released to the Department of Homeland Security and the Department of Health. This article first appeared on Mountain State Spotlight and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License. The post West Virginia Treasurer Allocates Medical Marijuana Revenue Despite Governor’s Veto appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Massachusetts lawmakers have negotiated the details of a bill to double the legal marijuana possession limit for adults and revise the regulatory framework for the state’s adult-use cannabis market. A bicameral conference committee has spent months working out provisions of the legislation after the House of Representatives and Senate passed differing versions last year, and the panel approved a compromise approach on Monday. Sen. Adam Gómez (D) and Rep. Daniel M. Donahue (D), who co-chaired the conference committee, said in a joint statement that the agreement “charts a more promising path forward for cannabis regulation in our Commonwealth.” “The legislation includes a new structure that provides clear accountability and enhances the operations of the Cannabis Control Commission (CCC),” the lawmakers, who also serve as co-chairs of the legislature’s Joint Cannabis Policy Committee, said. “The bill creates new opportunities for small businesses to grow, while providing those historically harmed by marijuana laws with temporary, exclusive access to those opportunities. This bill will allow them to realize their capital and pursue innovative models such as employee-owned businesses.” If approved in its final form by both chambers, which Gómez and Donahue said they expect to happen this week, the bill would then head to Gov. Maura Healey (D) for her signature. Gómez said at Monday’s conference committee meeting that the agreement represents “a forward-looking approach to modernize Massachusetts’s cannabis laws at a high level.” “This legislation recognizes that our cannabis industry has matured and that our regulatory framework must involve along with them,” he said. “The bill strengthens oversight and accountability by restructuring the Cannabis Control Commission, streamlining its leadership and clarifying goals and responsibilities so that the agency can operate more efficiently and transparently. We also make important improvements to public accountability by creating a new portal for reporting illegal conduct, requiring updated reporting on public health impacts and tax policy and studying workplace safety standards. The bill ensures that the industry continues to operate in a way that prioritizes safety, transparency and public trust. This legislation also supports economic opportunity and long-term sustainability by modernizing license caps and providing more flexibility in ownership structures. We help businesses—especially small and emerging operators—remain viable in the competitive market and by expanding pathways for participation by social equity businesses, including exclusive opportunities in the medical marijuana space. We reinforce our commitment to fairness and equitable access. We remove outdated and burdensome requirements such as the vertical integration mandate for medical operators that have created barriers to entry into growth. These changes help level the playing field and ensure that our cannabis economy reflects the diversity and the dynamics of the Commonwealth. Additionally, the bill expands safe and legal access to cannabis. It updates purchase and possession limits, it clarifies delivery rules to create consistency across municipalities and also allows for more modern and reasonable advertising practices within regulated environments. Finally, we take the important steps to address emerging issues in the marketplace, such as regulation of hemp-derived products and categories by directing further study and thoughtful policy development.” Among the proposed revisions to the state’s cannabis law is a section that would increase the personal possession limit for marijuana from one to two ounces. Colorado enacted the same reform in 2021 after that state’s cannabis market matured. In addition to the possession increase, which was included in both chambers’ versions, H.4206 would reduce the size and revise the organization of CCC, while also updating limits on marijuana business licensing. Under both chambers’ versions of the bill, CCC would be comprised of three members rather than the current five. The conference committee report adopts provisions from the House measure that would allow the governor to make all appointments, rather than the Senate approach to give one of the appointments to the attorney general. Under current law, the treasurer also plays a role in appointing commission members, but that will no longer be the case if the legislation is enacted. The new legislation requires that one member of CCC to have a background in social justice, while the other two commissioners need to have backgrounds in public health, public safety, social justice, consumer regulations or the production and distribution of cannabis. The bill will also increase the amount of licenses that a single entity can possess from three to six, while additionally raising from 10 percent to 20 percent the threshold of much equity in a business is considered ownership for the purpose of counting toward the cap on licenses. It also directs regulators to create a list of “delinquent” cannabis businesses that have not paid their debts to other operators for more than 60 days and prevents others from doing business with those on the delinquent list until debts are paid off. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — The cannabis regulation proposal’s advancement comes as marijuana businesses in the state have filed a lawsuit aiming to block an initiative to roll back the state’s voter-approved legalization law from reaching the November ballot. If passed, the state wouldn’t revert back to blanket prohibition; rather, it would repeal the commercial recreational sales and personal home cultivation components of the law while still allowing adults 21 and older to possess up to an ounce of cannabis for personal use. Possession of more than one ounce but less than two ounces would be effectively decriminalized, with violators subject to a $100 fine. Adults could also continue to gift cannabis between each other without remuneration. Medical marijuana sales would remain legal. The measure is currently before the legislature after supporters turned in an initial batch of signatures last year, and lawmakers have until May 5 to act on the proposal. If they choose not to enact it legislatively, the campaign would need to go through another round of petitioning and get at least 12,429 certified signatures by July 1 to make the November ballot. Proponents faced skeptical questioning from lawmakers at a hearing of the Joint Committee on Initiative Petitions last month, with several raising concerns about the motivations behind the anti-marijuana measure and its implications for consumers and businesses. A recent Bay State Poll from the University of Hampshire’s States of Opinion Project found that a majority of Massachusetts adults oppose the marijuana sales and cultivation repeal initiative. Meanwhile, in November, the legislature’s Joint Cannabis Policy Committee advanced a bill that would require a study into legal barriers facing first responders who wish to use marijuana in compliance with state law. Regulators would also need to look into the efficacy of marijuana in the treatment of anxiety, depression and post-traumatic stress disorder (PTSD). They would additionally examine laws and policies for cannabis use by police officers and first responders in other jurisdictions and “any other topics the commission deems relevant.” The bill was reported out as lawmakers in a different committee approved separate legislation to provide employment protections for people who use marijuana. Another panel advanced a similar cannabis employment protections bill in September. Meanwhile, the head of Massachusetts’s marijuana regulatory agency recently suggested that the measure to effectively recriminalize recreational cannabis sales could imperil tax revenue that’s being used to support substance misuse treatment efforts and other public programs. To that point, Massachusetts recently reached another marijuana milestone, with officials announcing in February that the state has surpassed $9 billion in adult-use cannabis purchases since the market launched in 2018. A report from the Cannabis Control Commission (CCC) found that legalization is achieving one of its primary goals: disrupting illicit cannabis sales as adults transition to the regulated market. It shows that among adults who reported past-year marijuana use, an overwhelming 84 percent said they obtained their cannabis from a licensed source. Massachusetts lawmakers also recently assembled a bicameral conference committee to reach a deal on a bill that would double the legal marijuana possession limit for adults and revise the regulatory framework for the state’s adult-use cannabis market. In December, state regulators also finalized rules for marijuana social consumption lounges. CCC recently launched an online platform aimed at helping people find jobs, workplace training and networking opportunities in the state’s legal cannabis industry. Separately, lawmakers are also advancing legislation to establish pilot programs for the regulated therapeutic use of psychedelics. The post Massachusetts Lawmakers Reach Deal To Double Marijuana Possession Limit And Restructure Cannabis Regulations appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Maine Republican lawmaker is calling out colleagues for killing his bill that would have allowed marijuana consumption lounges to operate in the state. On Monday, the House of Representatives voted 108-35 to adopt a committee’s recommendation not to pass the bill, LD 1365 from Rep. David Boyer (R). The lawmaker said members of his own party were “about split” on the vote, wheres the “vast majority” of Democrats voted against allowing his cannabis legislation to advance. Only seven Democrats voted against the Veterans and Legal Affairs Committee’s majority report recommending that the bill not pass, while 65 members of the party supported the move to kill the legislation. Among Republicans, 28 members voted against stalling the measure while 41 backed the motion. “Maine lawmakers showed their contempt for voters today by killing the cannabis hospitality lounge bill,” Boyer, who led the fight to pass cannabis legalization at the ballot about 10 years ago when he was a staffer for the Marijuana Policy Project (MPP), told Marijuana Moment. “This was a core provision of the 2016 citizens initiative that Maine voters approved nearly ten years ago to legalize adult-use cannabis and create safe, regulated social consumption spaces,” he said, referring to portions of the legalization ballot measure that were later negotiated out by the legislature’s Marijuana Legalization Implementation Committee. “There is no good reason to prohibit cannabis hospitality lounges when we allow adults to consume alcohol in public,” Boyer said “It’s time uphold the will of the voters and let adults be adults.” Under the bill, municipalities would be able to license cannabis hospitality lounges where adults over the age of 21 could consume marijuana products. Local officials could also set fees on the businesses. After being locally licensed, the facilities would not need additional approval from the Maine Office of Cannabis Policy or other state officials. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, a Maine campaign seeking to significantly roll back the state’s marijuana law failed to submit signatures by a recent deadline to make the November 2026 ballot, meaning the anti-cannabis activists will need to shift their focus to 2027 if they hope to put the issue before voters. If approved, the initiative would end regulated recreational marijuana sales as approved by voters in 2016. Possession of up to 2.5 ounces of cannabis would remain legal, but adults would no longer be able to grow plants for personal use or buy adult-use cannabis from licensed stores. The campaign behind the measure has criticism from reform advocates, industry stakeholders and certain lawmakers over allegedly misleading signature gathering tactics, Photo courtesy of Mike Latimer. The post Maine Lawmakers Reject Bill To Legalize Marijuana Consumption Lounges appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Advocates have long argued that marijuana legalization is a superior alternative to criminalization. But while that sentiment prevails with the public and a growing number of lammakers, a leading drug policy reform group says it’s nonetheless important to recognize and address potential public health impacts of consumer trends in state-regulated markets—including the rise of high-potency THC products. Prohibitionists have been quick to seize upon reports of adverse health incidents associated with products engineered to maximize THC, whether it’s naturally produced delta-9 THC in marijuana, synthetically manufactured delta-8 THC in hemp or any of the numerous other iterations of the intoxicating cannabinoid. But rather than revert to banning such products outright, officials should prioritize targeted regulations to balance public health and consumer choice, the pro-legalization Drug Policy Alliance (DPA) said in a new report titled “High-THC Marijuana: Protecting Public Health In A Changing Market.” “As product potency rises, so do important public health questions about safety, youth access, and consumer transparency,” it says, adding that DPA’s position is that “legalization must be paired with thoughtful, evidence-based regulation that protects health, enhances safety, and reduces harm.” The organization isn’t necessarily arguing that high-THC cannabis products present an imminent public health threat, pointing to the “mixed body of research” on the potential negative health impacts such as the development of cannabis use disorder, anxiety and other mental health conditions. But there is a need to expand research into the issue and inform public policy, particularly as it concerns youth use and access, DPA said. For some patients, higher concentrations of THC can “help manage pain and other medical conditions,” the report said, so regulations should “consider medical exemptions or alternate provisions to accommodate these patients’ needs.” At the same time, one of the group’s recommendations is to ensure that legal markets offer a diversified array of products that includes low-THC options for patients and consumers. Overall, one of DPA’s top recommendations is to create a “unified regulatory framework for all cannabinoids (including hemp-derived products like delta-8 THC) with consistent standards for testing, labeling, age restrictions, and consumer protections.” Other proposals essentially follow the same line of policy thinking that reform advocates have long pushed for as an alternative to criminalizing cannabis. That is, they want to see research (including opportunities for federal studies) expanded, restrictions such as age-gating enforced to mitigate youth access and tax revenue allocations that support mental health treatment and other public health initiatives. There should also be improvements in “consumer education and product transparency with standardized serving sizes, clear THC content labeling, prominent warning labels, retail education materials, and training for dispensary staff,” the report says. Because there may be health impacts associated with high-THC cannabis, policymakers should additionally consider potential alternatives to blanket bans that still aim to steer the market away from becoming oversaturated with such products. That could include setting prices based in part on THC potency, while also requiring low-THC product availability in the regulated market. Although the science and health impacts of high-THC cannabis is still being studied, one thing is undeniable: There has been a steady rise in the marketing and sale of such products as the state legalization movement has expanded and businesses have responded to consumer demand. DPA’s report is meant to respond to that reality, without ceding the issue to anti-legalization interests that have used fears about the use of these highly potent products to promote prohibitionist policies. Cat Packer, DPA’s director of legal regulation, said in a Q&A about the THC potency issue that “no one should be arrested for marijuana and policies cannot return to bringing back harmful and ineffective criminalization tactics.” “Legal regulation must address the ongoing harms of criminalization that impede on someone’s livelihood and basic needs,” she said. “At minimum, clearing records for all past marijuana arrests and convictions. Not having a criminal record removes barriers to economic opportunities and housing access. Ending criminalization also stops law enforcement from targeting certain communities.” The DPA report concludes by reiterating that high-THC marijuana products “pose complex regulatory challenges that demand a balanced, evidence-based response.” “As product potency increases and markets evolve, policy must keep pace. Failing to modernize regulatory frameworks poses threats to public health, particularly for youth and individuals vulnerable to mental and physical health issues and substance use disorders,” it says. “By aligning hemp and marijuana regulations, strengthening research and data collection, improving product transparency, and implementing safeguards for high-THC products, policymakers can reduce preventable harms while preserving access for adult consumers and medical patients,” it continues. “Public education, responsible retail practices, and reinvestment of tax revenue into treatment and prevention are critical to regulation that balances commercial interests with public health.” Aligning hemp and marijuana rules has become all the more urgently needed as the federal definition of hemp is set to fundamentally change later this year, with a significantly more restrictive threshold for THC to be considered legal hemp. Industry stakeholders say that policy change, which is set to take effect in November under a broader agriculture law President Donald Trump enacted last year, threatens to effectively eradicate the consumable cannabinoid market. “A strong regulatory framework that is grounded in evidence, health, and consumer protections offers the clearest path forward,” DPA said. “Policymakers should heed these recommendations to mitigate risks, promote informed decision-making, and ensure market innovations do not outpace health protections.” Meanwhile, amid shifting state and federal cannabis policies, the White House has scheduled several meetings with cannabis industry and research stakeholders to discuss a proposed enforcement policy for non-intoxicating CBD products. Also in the background, advocates and stakeholders are also eagerly awaiting the finalization of a rule to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). Trump signed an executive order in December directing the attorney general to expeditiously complete that process—which would help streamline cannabis research while allowing state-licensed businesses to take federal tax deductions—but that remains pending. The post Drug Reform Group Lays Out Options To Address High-THC Marijuana’s Risks Without Returning To Criminalization appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

thank you for creating this safe space for women to share their stories - it's so important that we lift each other up and know we're not alone. i appreciate the work you're doing at cookie clicker 2 to support this community.

“This is a careful bill for people, our veterans and first responders, who have carried extraordinary burdens.” By Rebecca Rivas, Missouri Independent After four years of trying, the Missouri House passed legislation Thursday that would require the state to conduct a study on using psilocybin—also known as “magic mushrooms”—and other alternative therapies to treat depression, substance use or as part end-of-life care. Veterans and first-responders would be able to possess the psychedelic if they’re enrolled in a study, where it would be administered by a facilitator. Despite overwhelming support for the idea in past years, Thursday marks the first time the House has sent the bill on to the Senate, with a vote of 137 to 11. Lawmakers amended the legislation last week to include ibogaine, a powerful psychoactive compound derived from an African shrub that’s used to treat addiction, PTSD and traumatic brain injury. Republican state Rep. Renee Reuter of Imperial gave an emotional account of her husband’s struggles with post-traumatic stress disorder during House debate last week. After serving overseas in the U.S. Army in 1993, her husband’s PTSD has “enticed him to do certain things” that have destroyed their marriage and lives. “When he left in 1993 I told my husband, ‘You do whatever you have to do, but come home,’” Reuter said. “In ‘94 when my husband came home, he didn’t come all the way home.” Her son has also been deployed three times overseas and experiences PTSD as well. “Let’s do this for those men and women,” she said. “Let’s give them whatever it is that we need to give them to help them and their families continue to live and be productive members of society.” While the bill was originally focused on helping veterans, Republican state Rep. Matthew Overcast pushed to expand the bill to also include first responders. In 2020, Overcast worked for a company that handled staffing for nurses in New York hospitals, and he saw how the pandemic impacted the hospital workers. “I can tell you from walking through some of those nursing wards,” said Overcast, who is also a veteran. “There was more death that they saw in those few months when it first hit, than even some of our own soldiers have seen in a war.” This bill requires the Missouri Department of Mental Health to provide grants totaling $2 million for the research on alternative therapies, subject to lawmakers approving the appropriation. The state would collaborate on the study with a Missouri university hospital or medical center operated by the U.S. Department of Veterans Affairs in Missouri. The focus of the treatment is on veterans suffering from post-traumatic stress disorder, depression, substance use disorders, or for those who require end-of-life care. The suicide rate among veterans in Missouri is nearly double the state rate and one of the highest in the country. “This is a careful bill for people, our veterans and first responders, who have carried extraordinary burdens that most of us could only be we can’t really even imagine,” Overcast said, “and they endured significant trauma, not only in service to our communities, but to our country as well. It is measured, it is compassionate and it is accountable.” The bill’s sponsor, Republican state Rep. Richard West of Wentzville, said as a former police officer, he was skeptical of alternative therapies at first. But he’s read the study results and believes states should support furthering the research. That includes studies done by psychiatry researchers at Washington University School of Medicine in St. Louis, who were the first in Missouri to give a legal dose of psilocybin in 2019. They have been using a brain-imaging technique to learn how psilocybin affects certain networks in the brain. Republican State Rep. Dave Griffith of Jefferson City, a veteran who has supported the measure for several years, said it was appropriate to add first responders as eligible participants. “I think the most important thing about this bill is going to be done under a controlled atmosphere,” Griffith said, before the House passed the bill Thursday. “There needs to be safeguards put in place for them. [West] set up all those guardrails for us, so I’d ask somebody to support this bill.” This story was first published by Missouri Independent. The post Missouri Lawmakers Pass Bill Supporting Psychedelics Research To Aid Military Veterans And First Responders appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Congressional lawmakers were recently presented with a unique argument in favor of expanding therapeutic access to cannabis and rescheduling marijuana under federal law: Doing so could mitigate threats associated with Chinese Community Party (CCP) operatives. At a hearing before the House Small Business Committee last month, members took expert testimony on a variety of challenges linked to CCP, including intellectual property theft, foreign investments and vulnerabilities in the supply chain that impact small U.S. companies. The hearing—titled “Defending Main Street: Combating CCP Threats to America’s Small Businesses” Summary”—involved testimony from Sean Murphy, founder of the nonprofit organization Kompassion that focuses on palliative care and rare diseases afflicting children. Murphy said his personal experience raising a child with a severe health condition as well as volunteering in veterans hospices informed his advocacy for cannabinoid research and reform. That includes a proposal to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA) to “unlock research and healing, especially for rare diseases,” he said. Rescheduling wouldn’t federally legalize cannabis, but it would remove certain Schedule I research barriers, while benefitting state-licensed marijuana businesses by allowing them to take federal tax deductions they’re currently barred from under an Internal Revenue Service (IRS) code known as 280E. The incremental change “will be a monumental movement in research and development of cures,” Murphy said in a written testimony submitted to the committee. And while marijuana remains Schedule I, President Donald Trump signed an executive order in December directing the attorney general to quickly finalize its reclassification under a process that was initiated under the Biden administration. As part of his testimony for the committee hearing, Murphy also included policy recommendations that he argued would help address lawmakers’ concerns by empowering U.S. entrepreneurs and small business owners in healthcare, while generally expanding their access to capital. One of the recommendations involves targeted funding for energetic medicine, palliative care and cannabinoid research through the Advanced Research Projects Agency for Health (ARPA-H) under the U.S. Department of Health and Human Services (HHS). With funding for ARPA-H currently at $1.5 billion for the 2026 fiscal year, a portion should be side aside to “explicitly” support initiatives such as cannabinoid research, “including new therapeutic pathways made possible by marijuana’s rescheduling from Schedule I to Schedule III,” the testimony says. “All mammals possess an endocannabinoid system (ESC) that plays a central role in inflammation reduction and homeostasis; targeted research in this area would unlock breakthrough whole-health approaches that treat the body’s nervous and endocannabinoid system, while supporting veteran and family care, all while keeping IP and data 100 percent secure from foreign exploitation,” it says. Cannabis policy also intersected with a congressional hearing focused on foreign threats last year, when a GOP-led House committee looked at challenges associated with Chinese criminal organizations behind large-scale illicit marijuana grows. Leveraging the increasing attention to the issue, the prohibitionist group Smart Approaches to Marijuana (SAM) put out an ad in July arguing that if President Donald Trump moved forward with a pending cannabis rescheduling proposal, it would empower Chinese cartels. In 2023, a major marijuana lobbying firm apologized after sending a letter to Senate committee leadership concerning a bipartisan cannabis banking bill that contained “inappropriate” references to investments from China in a “misguided attempt” to push for amendments expanding the legislation. The post Marijuana Rescheduling Could ‘Unlock Research’ To Treat Rare Diseases, Father Of Terminally Ill Child Tells Congressional Committee appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

FBI memo on marijuana investments; Another Medicare hemp coverage rule; NC governor pushes legalization; HI cannabis resolutions Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today. https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW President Donald Trump is proposing that Congress continue a rider protecting state medical cannabis laws from federal interference for the first time after suggesting its deletion in prior budget requests—but he is also asking lawmakers to keep blocking Washington, D.C. from legalizing recreational marijuana sales The Federal Bureau of Investigation declassified a guidance memo blocking agents from investing in or working at marijuana companies but allowing involvement with hemp and CBD businesses—except if their packaging depicts a cannabis leaf, which is considered “promotion of marijuana.” The Centers for Medicare & Medicaid Services filed a Federal Register notice finalizing a rule to allow coverage of some hemp products like hulled seed, seed protein powder and seed oil as specialized benefits through Medicare Advantage plans. North Carolina Gov. Josh Stein (D) is stepping up the push to legalize marijuana after the Advisory Council on Cannabis he appointed issued an interim report recommending the state move away from a criminalization-based approach and toward a system of “robust” regulations providing legal access to THC products. The Louisiana Senate Health and Welfare Committee approved a bill to allow patients with terminal and irreversible conditions to use medical marijuana in hospitals, subject to certain limitations. The Hawaii Senate Judiciary Committee approved resolutions calling on Congress to federally legalize marijuana, support state efforts to clear people’s conviction records and take steps to facilitate access to banking services for companies in the cannabis industry. Missouri lawmakers sent Gov. Mike Kehoe (R) a bill to ban intoxicating hemp products, protect marijuana consumers’ privacy and recognize cannabis industry workers’ right to unionize. / FEDERAL Rep. Jim Baird (R-IN) expressed his concerns about the pending federal recriminalization of hemp products at a House Appropriations Subcommittee Agriculture, Rural Development, Food and Drug Administration and Related Agencies hearing. / STATES Former New Jersey Gov. Chris Christie (R) discussed his opposition to legalizing marijuana. Delaware regulators filed proposed changes to marijuana product rules. Missouri regulators filed proposed rules to establish marijuana research facilities. Minnesota regulators published guidance about on-site cannabis consumption. New York’s new top marijuana regulator discussed his plans for overseeing the legal industry. Massachusetts regulators are investigating a whistleblower complaint against a marijuana business. New York cannabis regulators posted an updated form for reporting incidents or complaints. The Illinois Medical Cannabis Advisory Board will meet on Monday. The Georgia Access to Medical Cannabis Commission will meet on Wednesday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL Los Angeles, California regulators sent an update about various cannabis issues. / INTERNATIONAL Saint Kitts and Nevis Prime Minister Terrance Drew spoke about efforts to implement cannabis reform in a “careful and measured” way. Nepal local governments are taking steps to allow cannabis cultivation. / SCIENCE & HEALTH A study found that “Christian participants reported the most favorable views toward both medical and recreational cannabis, followed by Jewish respondents, while Muslim and Druze participants expressed more conservative attitudes.” A study found that “individuals purchased and consumed cannabis regardless of legal status and legal status was not significantly associated with harm or benefit rating, controlling for demographic and use data” and that “individuals appear more likely to purchase through legal means, if available.” / BUSINESS Curaleaf Holdings, Inc.’s chief legal officer extended an existing automatic securities disposition plan. Village Farms International, Inc.’s chief financial officer is leaving the post while remaining an employee of the company. / CULTURE Scarlett Johansson talked about seeing Cypress Hill smoke a very large blunt at the first concert she ever attended. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Trump puts medical cannabis protections in budget (Newsletter: April 6, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Interesting perspective on postpartum depression. While I appreciate the author's candidness, it's crucial to consult healthcare professionals. Individual experiences vary drastically. Perhaps incorporating discussion of professional therapy alongside alternative treatments, and risks, would offer a more balanced view. It reminds me of the focus and calm some find when playing Drift Boss – a temporary escape doesn't replace comprehensive care.

Wow, that's a powerful story! It's disheartening to hear about the lack of support and the reliance on potentially harmful medications like Oxycontin for postpartum depression. It's interesting to consider alternative approaches. It sounds like Samantha found something that worked for her, and it's great she's sharing her experience. It reminds me of simpler times, relaxing and just managing something simple, maybe like playing Papa's Freezeria. Every mom deserves access to options that truly help them, with open discussion and less stigma. Thanks for sharing!

A Louisiana Senate panel has advanced a bill to allow patients with terminal and irreversible conditions to use medical marijuana in hospitals. The Senate Health and Welfare Committee approved the legislation, SB 270 from Sen. Katrina Jackson-Andrews (D), with amendments, in a voice vote on Wednesday. “This bill was brought at the request of constituents who believe that therapeutic medical marijuana, which is already legal in this state, should be offered in hospitals when patients are terminally ill or otherwise in need the comfort of this medicine,” Jackson-Andrews said ahead of the vote. Under the proposal, hospitals would have to create written guidelines allowing covered patients to consume medical cannabis on-site in forms other than smoking or vaping. Under an amendment adopted by the panel, emergency or outpatient departments would be exempted from the policy. The revised legislation also clarifies that patients and primary caregivers are responsible for acquiring and administering medical marijuana, which must be “stored securely at all times in a locked container provided by the patient.” Health care professionals and staff would be prohibited from “administering, storing, retrieving, or assisting the patient with the medical marijuana,” the text says. The amendment, which the sponsor worked on with help from the Louisiana Hospital Association, also allows hospitals to opt out of the policy if federal officials take action against any healthcare facility in the state over medical cannabis use, rather than only allowing those that were specifically targeted to stop complying. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile in Louisiana, the Senate Health and Welfare Committee last week approved a bill to create a psychedelic-assisted therapy pilot program, using opioid settlement dollars to fund clinical trials aimed at developing alternative treatments such as psilocybin and ibogaine. Lawmakers are also considering a bill to create an adult-use marijuana legalization pilot program in the state to determine whether the reform should eventually be expanded and permanently codified. The post Louisiana Senators Approve Bill To Allow Medical Marijuana Use In Hospitals For Terminally Ill Patients appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

You there, this is really good post here. Thanks for taking the time to post such valuable information. Quality content is what always gets the visitors coming. live casino online

Your work is truly appreciated round the clock and the globe. It is incredibly a comprehensive and helpful blog. live casino

i love reading this article so beautiful!!great job! bolahit daftar

Positive site, where did u come up with the information on this posting?I have read a few of the articles on your website now, and I really like your style. Thanks a million and please keep up the effective work. situs kebun4d

The legislation also has provisions to protect marijuana consumers’ privacy and cannabis workers’ right to unionize. By Rebecca Rivas, Missouri Independent A bill now heading to Missouri Gov. Mike Kehoe’s (R) desk would take all intoxicating hemp products off the shelves starting November 12—including THC seltzers currently sold in bars and grocery stores—aligning state law with an upcoming federal ban. If Congress reverses course and decides to allow the sale of these products, Missouri would only permit them to be sold in licensed marijuana dispensaries. And if Congress chooses to delay the ban for a couple years, Missouri would still ban all products, except for the sale of intoxicating beverages in dispensaries. The House passed a bill sponsored by Republican state Rep. Dave Hinman of O’Fallon with a vote of 126 to 23. It passed the Senate Tuesday night and now heads to the governor for his signature or veto. The bill also includes provisions to protect marijuana consumer privacy and cannabis workers’ right to organize, which were amendments state senators added late Tuesday evening. Hinman’s legislation was one of the first bills to get House approval this year. He previously told The Independent the legislation was a priority for the state’s leadership, including the governor, attorney general and House speaker. Intoxicating hemp products with as much as 1,000 mg of THC are being sold in smoke shops—outside of Missouri’s licensed marijuana dispensaries—and they aren’t regulated by any government agency. Missouri lawmakers have failed to pass legislation regulating these products since 2023. The bill comes amidst uncertainty on where the federal government will finally land on regulations for these products. President Donald Trump signed an executive order in December ordering his administration to work with Congress to develop a framework that permits full-spectrum CBD products, which have a trace amount of THC. On Wednesday, the Centers for Medicare & Medicaid Services rolled out an initiative that could cover $500 per year worth of hemp-derived THC of 3mg per serving and CBD products for eligible users. The products under this program would be illegal in Missouri under the bill approved Thursday. This story was first published by Missouri Independent. The post Missouri Lawmakers Pass Bill To Ban Intoxicating Hemp THC Products, Sending It To Governor appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Love to read it,Waiting For More new Update and I Already Read your Recent Post its Great Thanks. landing page copywriting

The atmosphere of the New Delhi Escort Service can be characterized by a smooth and friendly tone, in which elegant figures and friendly communication form the atmosphere that makes it easy to talk and feel a soft feeling of connection.

This is my first visit to your web journal! We are a group of volunteers and new activities in the same specialty. Website gave us helpful data to work. koi toto